Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance

Resistance to treatment with anticancer drugs is a significant obstacle and a fundamental cause of therapeutic failure in cancer therapy. Functional doxorubicin (DOX) nanoparticles for targeted delivery of the classical cytotoxic anticancer drug DOX to tumor cells, using folate-terminated polyrotaxa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Wang, He, Yin, Henghui, Yan, Fengjiao, Sun, Mingna, Du, Lingran, Peng, Wei, Li, Qiuli, Feng, Yinghong, Zhou, Yi
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2014
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413620/
https://ncbi.nlm.nih.gov/pubmed/25605018
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires